BH3-only proteins are dispensable for apoptosis induced by pharmacological inhibition of both MCL-1 and BCL-X-L



Greaves, Georgia, Milani, Mateus, Butterworth, Michael, Carter, Rachel J, Byrne, Dominic P, Eyers, Patrick A ORCID: 0000-0002-9220-2966, Luo, Xu, Cohen, Gerald M and Varadarajan, Shankar ORCID: 0000-0002-8827-6567
(2019) BH3-only proteins are dispensable for apoptosis induced by pharmacological inhibition of both MCL-1 and BCL-X-L. CELL DEATH AND DIFFERENTIATION, 26 (6). pp. 1037-1047.

This is the latest version of this item.

[img] Text
31282_1_merged_1532353190.pdf - Author Accepted Manuscript

Download (13MB)
[img] Text
Greaves et al CDD 2018.pdf - Published version

Download (1MB)

Abstract

The impressive selectivity and efficacy of BH3 mimetics for treating cancer has largely been limited to BCL-2 dependent hematological malignancies. Most solid tumors depend on other anti-apoptotic proteins, including MCL-1, for survival. The recent description of S63845 as the first specific and potent MCL-1 inhibitor represents an important therapeutic advance, since MCL-1 is not targeted by the currently available BH3 mimetics, Navitoclax or Venetoclax, and is commonly associated with chemoresistance. In this study, we confirm a high binding affinity and selectivity of S63845 to induce apoptosis in MCL-1-dependent cancer cell lines. Furthermore, S63845 synergizes with other BH3 mimetics to induce apoptosis in cell lines derived from both hematological and solid tumors. Although the anti-apoptotic BCL-2 family members in these cell lines interact with a spectrum of pro-apoptotic BH3-only proteins to regulate apoptosis, these interactions alone do not explain the relative sensitivities of these cell lines to BH3 mimetic-induced apoptosis. These findings necessitated further investigation into the requirement of BH3-only proteins in BH3 mimetic-mediated apoptosis. Concurrent inhibition of BCL-XL and MCL-1 by BH3 mimetics in colorectal HCT116 cells induced apoptosis in a BAX- but not BAK-dependent manner. Remarkably this apoptosis was independent of all known BH3-only proteins. Although BH3-only proteins were required for apoptosis induced as a result of BCL-XL inhibition, this requirement was overcome when both BCL-XL and MCL-1 were inhibited, implicating distinct mechanisms by which different anti-apoptotic BCL-2 family members may regulate apoptosis in cancer.

Item Type: Article
Uncontrolled Keywords: Cells, Cultured, Humans, Pyrimidines, Thiophenes, Mitochondrial Membrane Transport Proteins, Cell Death, Apoptosis, Structure-Activity Relationship, Dose-Response Relationship, Drug, bcl-X Protein, Myeloid Cell Leukemia Sequence 1 Protein
Depositing User: Symplectic Admin
Date Deposited: 22 Nov 2018 10:08
Last Modified: 19 Jan 2023 01:12
DOI: 10.1038/s41418-018-0183-7
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3028996

Available Versions of this Item